The molecular biology enzymes, kits, and reagents market in Europe is expected to grow from US$ 4,125.28 million in 2021 to US$ 12,561.60 million by 2028; it is estimated to grow at a CAGR of 17.2% from 2021 to 2028.
France, Germany, Italy, Spain, and UK are major economies in Europe. Sequencing procedures becoming cheaper is the major factor driving the growth of the Europe molecular biology enzymes, kits, and reagents market. The cost of genome sequencing, as well as next-generation sequencing, has dropped radically in the past 6–7 years. For instance, the whole human genome sequencing cost was ~US$ 3.7 billion in 2000, and the process took more than a decade for the completion. However, the costs of this process dropped down to US$ 10 million in 2006 and US$ 5,000 in 2012; it has further reduced to US$ 1,000 in recent years. Moreover, the process requires a lesser number of days for completion. In 2003, the International Human Genome Sequencing Consortium started the genome analysis by sequencing a complete human genome. The sequencing cost was ~US$ 2.6 billion (EUR 2.3 billion). By 2008, costs dropped to lower than US$ 1.4 million (EUR 1 billion) per genome. However, now, it costs US$ 400–500 to sequence an exome and US$ 1,000–1,200 to sequence a genome. The decline in the cost can be checked by the cost to sequence a genome diverging drastically around 2008, falling from approximately US$ 10 million to nearly US$ 1,000 at the present date. Lowering costs and accelerating the overall process would enable service providers to secure larger profit margins, along with helping them expand their clientele. The latest machines offered by Illumina are a lower priced and are available in two models—NovaSeq 5000 priced at US$ 850,000 and NovaSeq 6000 priced at US$ 985,000. DNA sequencing company, Illumina introduced its first machine for the human genome sequencing for US$ 300,000 in 2006, and in 2014, it unveiled the machine at a cost reduced to US$ 1,000. Thus, the lowered cost of genome sequencing is propelling the number of molecular biology procedures carried out for different purpose, thereby driving the use of enzymes, kits, and reagents.Italy, Spain, the UK, Germany, France, and several other European counties such as Russia and Switzerland were highly affected. The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK were among the most affected European countries, and the number of deaths was also high. The COVID-19 outbreak has been declared by the World Health Organization (WHO) as a Public Health Emergency of International Concern, according to the International Health Regulations. Increasing number of product launches in 2020 and the rising incidence of COVID-19 have positively impacted the Europe molecular biology enzymes, kits & reagents market. In 2020, European Medicines Agency (EMA) approved about 97 medicines for marketing authorization, of which 39 are novel drugs. Similarly, in October 2020, Eurofins introduced COVID-19 PCR tests with at-home self-sampling options in Europe.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe molecular biology enzymes, kits, and reagents market. The Europe molecular biology enzymes, kits, and reagents market is expected to grow at a good CAGR during the forecast period.
Europe Molecular Biology Enzymes, Kits, and Reagents Market Segmentation
Europe Molecular Biology Enzymes, Kits, and Reagents Market – By Product
- Enzymes
- Polymerases
- Ligases
- Reverse Transcriptases
- Phosphatases
- Proteases and Proteinases
- Restriction Endonuclease
- Other
- Kits and Reagents
Europe Molecular Biology Enzymes, Kits, and Reagents Market – By Application
- Epigenetics
- Sequencing
- Synthetic Biology
- Polymerase Chain Reaction
- Other
Europe Molecular Biology Enzymes, Kits, and Reagents Market – By End User
- Biotechnological and Pharmaceutical Companies
- Hospitals and Diagnostic Centres
- Academic and Research Institutes
Europe Molecular Biology Enzymes, Kits, and Reagents Market, by Country
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Europe Molecular Biology Enzymes, Kits, and Reagents Market - Companies Mentioned
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Molecular Biology Enzymes, Kits & Reagents Market – By Product
1.3.2 Europe Molecular Biology Enzymes, Kits & Reagents Market – By Application
1.3.3 Europe Molecular Biology Enzymes, Kits & Reagents Market – By End-User
1.3.4 Europe Molecular Biology Enzymes, Kits & Reagents Market – By Country
2. Europe Molecular Biology Enzymes, Kits & Reagents Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Molecular Biology Enzymes, Kits & Reagents Market – Market Landscape
4.1 Europe PEST Analysis
4.1.1 Expert Opinion
5. Europe Molecular Biology Enzymes, Kits & Reagents Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Genomics Getting Financial Assistance
5.1.2 Sequencing Procedures Becoming Cheaper
5.1.3 Chronic Diseases Becoming More Prevalent
5.2 Market Restraints
5.2.1 Lack of Skilled Professionals
5.3 Market Opportunities
5.3.1 Surge in Acceptance of Molecular Diagnostics
5.4 Future Trends
5.4.1 Personalized Medicines at Huge Demand
5.5 Impact analysis
6. Molecular Biology Enzymes, Kits & Reagents Market – Europe Analysis
6.1 Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Forecast and Analysis
7. Europe Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Product
7.1 Overview
7.2 Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
7.3 Enzymes
7.3.1 Overview
7.3.2 Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Polymerases
7.3.3.1 Overview
7.3.3.2 Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Ligase
7.3.4.1 Overview
7.3.4.2 Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Reverse Transcriptases
7.3.5.1 Overview
7.3.5.2 Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.6 Phosphatases
7.3.6.1 Overview
7.3.6.2 Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.7 Proteases and Proteinases
7.3.7.1 Overview
7.3.7.2 Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.8 Restriction Endonuclease
7.3.8.1 Overview
7.3.8.2 Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.3.9 Other
7.3.9.1 Overview
7.3.9.2 Other: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Kits and Reagents
7.4.1 Overview
7.4.2 Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8. Europe Molecular Biology Enzymes, Kits & Reagents Market Analysis – By Application
8.1 Overview
8.2 Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
8.3 Polymerase Chain Reaction
8.3.1 Overview
8.3.2 Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Sequencing
8.4.1 Overview
8.4.2 Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Synthetic Biology
8.5.1 Overview
8.5.2 Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Epigenetics
8.6.1 Overview
8.6.2 Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Molecular Biology Enzymes, Kits & Reagents Market – By End User
9.1 Overview
9.2 Europe Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
9.3 Biotechnological and Pharmaceutical Companies
9.3.1 Overview
9.3.2 Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Diagnostic Centers
9.4.1 Overview
9.4.2 Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Molecular Biology Enzymes, Kits & Reagents Market – Country Analysis
10.1 Overview
10.1.1 Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
10.1.1.1 Germany
10.1.1.1.1 Germany: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.1.3 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.1.4 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.1.5 Germany: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.2 France
10.1.1.2.1 France: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2 France: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.2.3 France: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.2.4 France: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.2.5 France: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.3 United Kingdom
10.1.1.3.1 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.3.3 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.3.4 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.3.5 United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.4 Italy
10.1.1.4.1 Italy: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.2 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.4.3 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.4.4 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.4.5 Italy: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.5 Spain
10.1.1.5.1 Spain: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.2 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.5.3 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.5.4 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.5.5 Spain: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
10.1.1.6 Rest of Europe
10.1.1.6.1 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.2 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Product, 2019–2028 (USD Million)
10.1.1.6.3 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes, 2019–2028 (USD Million)
10.1.1.6.4 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Application, 2019–2028 (USD Million)
10.1.1.6.5 Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2019–2028 (USD Million)
11. Impact of COVID-19 Pandemic on Europe Molecular Biology Enzymes, Kits & Reagents Market
11.1 Europe: Impact Assessment of COVID-19 Pandemic
12. Molecular Biology Enzymes, Kits & Reagents Market Industry Landscape
12.1 Overview
12.2 Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
12.3 Organic Growth Strategies
12.3.1 Overview
12.3.2 Recent Organic Developments in the Molecular Biology Enzymes, Kits & Reagents Market
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 MERCK KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Illumina, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 QIAGEN
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Agilent Technologies, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Jena Bioscience GmbH
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 THERMO FISHER SCIENTIFIC INC.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 MERIDIAN BIOSCIENCE, INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Promega Corporation
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 2. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 3. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Germany: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. France: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 6. France: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 7. France: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. France: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 10. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 11. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 12. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 14. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 15. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 17. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 18. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 19. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 20. Spain: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Product– Revenue and Forecast to 2028 (USD Million)
Table 22. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 23. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 24. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 25. Recent Inorganic Developments In The Molecular Biology Enzymes, Kits & Reagents Market
Table 26. Glossary of Terms, Molecular Biology Enzymes, Kits & Reagents Market
LIST OF FIGURES
Figure 1. Europe Molecular Biology Enzymes, Kits & Reagents Market Segmentation
Figure 2. Europe Molecular Biology Enzymes, Kits & Reagents Market Segmentation, By Country
Figure 3. Europe Molecular Biology Enzymes, Kits & Reagents Market Overview
Figure 4. Kits and Reagents Segment Held Largest Share of Europe Molecular Biology Enzymes, Kits & Reagents Market
Figure 5. UK to Show Remarkable Growth During Forecast Period
Figure 6. Europe PEST Analysis
Figure 7. Europe Molecular Biology Enzymes, Kits, and Reagents Market Impact Analysis of Driver and Restraints
Figure 8. Europe Molecular Biology Enzymes, Kits & Reagents Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Product (2020 and 2028)
Figure 10. Europe Enzymes: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Europe Polymerases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Ligase: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Reverse Transcriptases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Phosphatases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Proteases and Proteinases: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Europe Restriction Endonuclease: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Kits and Reagents: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Europe Molecular Biology Enzymes, Kits & Reagents Market Revenue Share, by Application (2020 and 2028)
Figure 20. Europe Polymerase Chain Reaction: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe Sequencing: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Europe Synthetic Biology: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Europe Epigenetics: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Europe Others: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Europe Molecular Biology Enzymes, Kits & Reagents Market, by End User, 2020 and 2028 (%)
Figure 26. Europe Biotechnological and Pharmaceutical Companies: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Europe Hospitals and Diagnostic Centers: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Europe Academic and Research Institute: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Key Country – Revenue (2020) (USD Million)
Figure 30. Europe: Molecular Biology Enzymes, Kits & Reagents Market, by Country, 2020 & 2028 (%)
Figure 31. Germany: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. France: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. United Kingdom: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Italy: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Spain: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Europe: Molecular Biology Enzymes, Kits & Reagents Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in European Country Markets
Figure 38. Growth Strategies In The Molecular Biology Enzymes, Kits & Reagents Devices Market, 2018-2021
- Agilent Technologies, Inc.
- F. HOFFMANN-LA ROCHE LTD
- Illumina, Inc.
- Merck KGAA
- MERIDIAN BIOSCIENCE, INC
- Promega Corporation
- Qiagen
- Rockland Immunochemicals Inc
- THERMO FISHER SCIENTIFIC INC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Nov 2021
ECG Monitoring Equipment Market
Size and Forecast (2021-2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG, Stress ECG, Holter Monitors, and Cardiopulmonary Stress Testing Monitors), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Wound Closure Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sutures, Adhesives, Staplers, Strips, and Others), Wound Type (Chronic Wound and Acute Wound), End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Others), and Geography
Nov 2021
Cell and Gene Therapy Contract Development and Manufacturing Organization Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type (Drug Development and Manufacturing, Testing and Regulatory Services, and Others), Product Type (Gene Therapy and Cell Therapy), End User (Pharmaceutical Companies, Biopharmaceutical Companies, and Others), and Geography
Nov 2021
Pediatric Cardiology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (Transcatheter Heart Valves, Occlusion Devices, Catheters, Stents, Introducer Sheaths, and Others), Disease Indication (Congenital Heart Disease, Acquired Heart Disease, Arrhythmias, Cardiomyopathies, and Others), Surgical Procedure (Interventional Procedures, Heart Rhythm Management Procedures, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Pharmaceutical Membrane Filters Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Microfiltration, Ultrafiltration, Reverse Osmosis and Nanofiltration), Design (Hollow Fiber, Spiral Wound, Tubular System and Plate and Frame), Material (Polyethersulfone (PES), Polysulfone (PS), Cellulose-Based Membranes, Polytetrafluoroethylene (PTFE), Polyvinyl Chloride (PVC), Polyacrylonitrile (PAN) and Others), End User (Pharmaceutical and Biotech Industries and CROs and CDMOs), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, South & Central America)
Nov 2021
ECG Devices Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Resting ECG and Stress ECG), Lead Type (12-Lead ECG, 3–6 Lead ECG, and Single Lead), Technology [Portable (Wired) ECG System and Wireless ECG System], End User (Hospital and Clinics, Ambulatory Surgical Centers, Cardiac Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Nov 2021
Surgical Laser Fiber Units Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (CO2 Laser, Diode Laser, Erbium Laser, Nd:YAG Laser, Holmium Laser, Alexandrite Laser, and Others), Material (Silica-Based Fibers, Quartz Fibers, Polymer-Based Fibers, Multimode Fibers, and Others), Power (Low-Power Lasers, Medium-Power Lasers, and High-Power Lasers), Application (Urology, Dermatology, Gynecology, Cardiology, Neurology, Ophthalmology, Respiratory, Dentistry and Others), Wavelength (9,301 nm and above, 2,941–9,300 nm, and 1,441–2,940 nm, 821–1,440 nm, 710–820 nm, and below 710 nm), End User (Hospitals, Specialty Clinics, Physician Office, and Others), and Geography
Nov 2021
Therapeutic Vaccines Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Cancer Vaccines, Infectious Disease Vaccines, and Others), Technology (Allogenic Vaccines and Autologous Vaccines), End User (Hospitals, Clinics, and Others), and Geography
Get Free Sample For